Temperature Regulation Following Systemic Anticholinergic or Anticholinesterase Therapy

reportActive / Technical Report | Accession Number: ADA212155 | Open PDF

Abstract:

The effect of systemic atropine ATR, 2 mg, im or pyridostigmine PYR, 30 mg, oral at rest and during moderate seated cycle exercise was evaluated in two separate protocols at an ambient temperature of 30 C. Esophageal Tes and mean weighted skin temperatures were measured continuously, as was forearm sweating rate, forearm blood flow FBF, venous occlusion plethesmography and cutaneous perfusion SkBF, laser doppler velociometry. Whole body sweating decreased 55 P0.05 in ATR, while heart rate increased 30 bpm P0.05. ATR increased the slope central thermosensitivity of FBF Tes 90 P0.05 compared to control. The Tes for sweating onset was increased 0.3 C P0.05 after ATR.

Security Markings

DOCUMENT & CONTEXTUAL SUMMARY

Distribution:
Approved For Public Release
Distribution Statement:
Approved For Public Release; Distribution Is Unlimited.

RECORD

Collection: TR
Identifying Numbers
Subject Terms